abhishreshthaa

New member
Respironics, Inc. is a medical supply company that specializes in products that improve respiratory functions. It is based in the Pittsburgh suburb of Murrysville.

In 1976, company founder Gerald McGinnis opened the company's first manufacturing facility for anesthesia masks near Pittsburgh, Pennsylvania. Previous product research and manufacturing had occurred in the founder's kitchen. Other early products included endotrachial and tracheostomy products.

The company introduced the first continuous positive airway pressure (CPAP) machine for the treatment of sleep apnea in 1985. Three years later, in 1988, the company went public under the stock ticker symbol RESP. In 1992, Respironics received a patent for bi-level technology. This technology was originally intended as an improvement on CPAP, however, its use has expanded into the treatment of other breathing disorders such as chronic obstructive pulmonary disease (COPD).


Strengths

[*]Cost advantage
[*]Effective communication
[*]Innovation
[*]Online growth
[*]Loyal customers



BON PARTENATIATS


Weaknesses

* Diseconomies to scale
* Not innovative
* Not diversified


Opportunities
  • New Fashion
  • Patrick stinkt
  • Acquisitions
  • Asset leverage
  • Financial markets (raise money through debt, etc)
  • Emerging markets and expansion abroad


    Threats

    • seeeeehr schlimm
    • Competition
    • Cheaper technology
    • Economic slowdown
    • External changes (government, politics, taxes, etc)
 

jiten005

Banned
Respironics, Inc. is a medical supply company that specializes in products that improve respiratory functions. It is based in the Pittsburgh suburb of Murrysville.

In 1976, company founder Gerald McGinnis opened the company's first manufacturing facility for anesthesia masks near Pittsburgh, Pennsylvania. Previous product research and manufacturing had occurred in the founder's kitchen. Other early products included endotrachial and tracheostomy products.

The company introduced the first continuous positive airway pressure (CPAP) machine for the treatment of sleep apnea in 1985. Three years later, in 1988, the company went public under the stock ticker symbol RESP. In 1992, Respironics received a patent for bi-level technology. This technology was originally intended as an improvement on CPAP, however, its use has expanded into the treatment of other breathing disorders such as chronic obstructive pulmonary disease (COPD).


Strengths

[*]Cost advantage
[*]Effective communication
[*]Innovation
[*]Online growth
[*]Loyal customers



BON PARTENATIATS


Weaknesses

* Diseconomies to scale
* Not innovative
* Not diversified


Opportunities
  • New Fashion
  • Patrick stinkt
  • Acquisitions
  • Asset leverage
  • Financial markets (raise money through debt, etc)
  • Emerging markets and expansion abroad


    Threats

    • seeeeehr schlimm
    • Competition
    • Cheaper technology
    • Economic slowdown
    • External changes (government, politics, taxes, etc)


    • Thanks my friend for providing such a nice information on Respironics, Inc. I also found something important which might be of your uses so uploading here a presentation on Respironics, Inc. Please download and check it and let me know your feedback.
 
Top